As biopsy or puncture of the tumor at this time of the disease is not always possible or does not permit to collect enough material for deep sequencing analysis, the study of free circulating DNA by ddPCR appears as a reliable, noninvasive blood test to assess ALK mutational status at F1174 and R1275 hotspots. Here, ALK is linked to neoplasm.